EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk human papillomavirus testing in cervical cancer screening

Ju-Hyun Kim, Seung-Hyuk Shim, Kyung-Jin Min, Jae-Kwan Lee, Chong Woo Yoo, Min-Jung Kwon, Shin-Wha Lee, Jaeman Bae

Obstetrics & Gynecology Science · 15.03.2026 · 69 (2) · 85-93

DOI: 10.5468/ogs.26066 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Obstetrics & Gynecology Science, erschienen am 15.03.2026. Verfasst von Ju-Hyun Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-risk human papillomavirus (hrHPV) is an important cause of cervical cancer. hrHPV testing has emerged as an effective screening modality to address the limitations of cytology-based screening. However, in Korea, the absence of standardized clinical guidance has resulted in variability in practice. This consensus-based clinical practice guideline was developed by a multidisciplinary expert committee under the Korean Society of Gynecologic Oncology and includes specialists in gynecologic oncology, pathology, laboratory medicine, and public health. Relevant domestic and international evidence was systematically reviewed and perspectives from diverse clinical settings were incorporated through four public hearings. The final recommendations were established through expert consensus. These guidelines present four key recommendations. First, hrHPV testing may be considered for women aged ≥25 years, with a screening interval of 3 to

Schlagwörter

Stichwörter der Autor:innen

Cancer screeningClinical practice guidelineHuman papillomavirus DNA testsUterine cervical neoplasms

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Korea University School of Medicine, Ansan, Korea.
  • Department of Obstetrics and Gynecology, Korea University Guro Hospital, Korea University School of Medicine, Seoul, Korea.
  • Department of Pathology, National Cancer Center, Goyang, Korea.
  • Department of Laboratory Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

Förderung

  • National Cancer Center
  • Ministry of Health and Welfare

Zitieren

APA

Kim, J. H., Shim, S. H., Min, K. J., Lee, J. K., Yoo, C. W., Kwon, M. J., Lee, S. W., & Bae, J. (2026). Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk human papillomavirus testing in cervical cancer screening. Obstetrics & Gynecology Science, 69(2), 85-93. https://doi.org/10.5468/ogs.26066

Vancouver

Kim JH, Shim SH, Min KJ, Lee JK, Yoo CW, Kwon MJ, et al. Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk human papillomavirus testing in cervical cancer screening. Obstetrics & Gynecology Science. 2026;69(2):85-93. doi:10.5468/ogs.26066

BibTeX
@article{Kim2026,
  author = {Kim, Ju-Hyun and Shim, Seung-Hyuk and Min, Kyung-Jin and Lee, Jae-Kwan and Yoo, Chong Woo and Kwon, Min-Jung and Lee, Shin-Wha and Bae, Jaeman},
  title = {Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk human papillomavirus testing in cervical cancer screening},
  journal = {Obstetrics & Gynecology Science},
  year = {2026},
  volume = {69},
  number = {2},
  pages = {85--93},
  doi = {10.5468/ogs.26066}
}
Kostenlos starten →